Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | April 23, 2019 | April 24, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date April 23, 2019 · Filed April 24, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 169,935 |
Ending reported balance
After 2019-04-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-04-23 · Exercise / conversion · Acquired 56,000 · Balance 225,935 Row 2 · 2019-04-23 · Sale · Disposed 56,000 · Balance 169,935 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.00 · Expires 2025-02-19 | Direct | 113,227 |
Reported balance
After 2019-04-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-04-23 · Exercise / conversion · Disposed 56,000 · Balance 113,227 F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 1,698 |
Reported balance
Holding disclosure · report date 2019-04-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,698 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2019. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy Spouse | 53 |
Reported balance
Holding disclosure · report date 2019-04-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 53 F2: The reporting person disclaims beneficial ownership of all securities held by his spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 23, 2019.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,304 | $47.82 | $62,357.28 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 21,975 | $53.00 | $1,164,675.00 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,744 Read SEC document |
| February 01, 2007 Filed Feb 5, 2007 23:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 29,822 | $33.23 | $991,026.81 |
DisclosureSEC source: 0001104659-07-007299 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption right to buy · Derivative | 915 | $0.00 Strike: $41.01 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 915 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption right to buy · Derivative | 1,516 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,516 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption right to buy · Derivative | 4,293 | $0.00 Strike: $45.77 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 4,293 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption right to buy · Derivative | 620 | $0.00 Strike: $41.92 | $0.00 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 620 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from section 16(b) under Rule 16 b-3. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,344 | $52.62 | $386,441.28 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,897 Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 915 | $41.01 | $37,524.15 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,516 | $42.42 | $64,312.66 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,293 | $45.77 | $196,483.31 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 620 | $41.92 | $25,987.36 |
DisclosureSEC source: 0001104659-07-006231 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,876 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 11 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,876 Underlying: Common shares · 11,876 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 3,003 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 10 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,003 Underlying: Common shares · 3,003 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,304 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 9 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,304 Underlying: Common shares · 1,304 shares Expires 2007-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 14,567 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 8 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,635 Underlying: Common shares · 14,567 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,720 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,065 Underlying: Common shares · 3,720 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,274 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,274 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 16,183 | $47.82 | $773,871.06 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,539 Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 14,567 | $33.23 | $484,081.80 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,720 | $32.61 | $121,313.29 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2006 Filed Aug 2, 2006 22:46 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,274 | $27.43 | $62,382.19 |
DisclosureSEC source: 0001104659-06-050795 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2006 Filed Sep 14, 2006 18:57 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,636 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-061116 · a4a.xml · derivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,636 Underlying: Common shares · 11,636 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. F1 · kind: Due to an administrative error, the number of shares previously reported as having been used to pay for his July 31 exercises and the number of shares granted as replacement options with respect to those exercises were incorrect. This Form 4 reports the correct numbers. Read SEC document |
| July 31, 2006 Filed Sep 14, 2006 18:57 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,885 | $0.00 Strike: $47.82 | $0.00 |
DisclosureSEC source: 0001104659-06-061116 · a4a.xml · derivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,885 Underlying: Common shares · 2,885 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. F1 · kind: Due to an administrative error, the number of shares previously reported as having been used to pay for his July 31 exercises and the number of shares granted as replacement options with respect to those exercises were incorrect. This Form 4 reports the correct numbers. Read SEC document |
| July 31, 2006 Filed Sep 14, 2006 18:57 UTC Amendment | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 15,825 | $47.82 | $756,751.50 |
DisclosureSEC source: 0001104659-06-061116 · a4a.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,897 F1 · kind: Due to an administrative error, the number of shares previously reported as having been used to pay for his July 31 exercises and the number of shares granted as replacement options with respect to those exercises were incorrect. This Form 4 reports the correct numbers. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 21:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 480 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-06-045401 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 480 shares Expires 2006-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 21:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,800 | $0.00 Strike: $41.01 | $0.00 |
DisclosureSEC source: 0001104659-06-045401 · a4.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 3,800 shares Expires 2006-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 21:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 480 | $43.43 | $20,846.40 |
DisclosureSEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,161 Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 21:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 480 | $42.42 | $20,362.85 |
DisclosureSEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 21:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,800 | $43.00 | $163,400.00 |
DisclosureSEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,161 Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 21:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,800 | $41.01 | $155,838.00 |
DisclosureSEC source: 0001104659-06-045401 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 29, 2006 Filed Jun 30, 2006 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 163 | $0.00 Strike: $41.92 | $0.00 |
DisclosureSEC source: 0001104659-06-044878 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 163 shares Expires 2006-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 29, 2006 Filed Jun 30, 2006 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 163 | $42.92 | $6,995.96 |
DisclosureSEC source: 0001104659-06-044878 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,161 Read SEC document |
| June 29, 2006 Filed Jun 30, 2006 19:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 163 | $41.92 | $6,832.16 |
DisclosureSEC source: 0001104659-06-044878 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2006 Filed Jun 28, 2006 21:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,500 | $42.01 | $105,025.00 |
DisclosureSEC source: 0001104659-06-044171 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,161 Read SEC document |
| June 02, 2006 Filed Jun 5, 2006 19:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 174 | $43.16 | $7,509.84 |
DisclosureSEC source: 0001104659-06-039716 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,661 Read SEC document |
| June 01, 2006 Filed Jun 5, 2006 19:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 511 | $42.95 | $21,947.45 |
DisclosureSEC source: 0001104659-06-039716 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,835 Read SEC document |
| February 21, 2006 Filed Feb 22, 2006 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 137 | $43.86 | $6,008.82 |
DisclosureSEC source: 0001104659-06-011233 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,346 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 403 | $44.15 | $17,792.45 |
DisclosureSEC source: 0001104659-06-011233 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,983 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011233 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common shares · 83,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 02/17/2007, 27,667 on 02/17/2008 and 27,666 on 02/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011233 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,483 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5 year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 13,194 | $0.00 Strike: $43.00 | $0.00 |
DisclosureSEC source: 0001104659-06-005421 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,194 Underlying: common shares · 13,194 shares Expires 2010-02-10 F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 15,799 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-06-005421 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,785 Underlying: common shares · 15,799 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 13,194 | $43.00 | $567,342.00 |
DisclosureSEC source: 0001104659-06-005421 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,386 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:04 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 15,799 | $32.61 | $515,222.77 |
DisclosureSEC source: 0001104659-06-005421 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 10,642 | $0.00 Strike: $48.33 | $0.00 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,642 Underlying: common shares · 10,642 shares Expires 2010-02-10 F5 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 13,251 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,584 Underlying: common shares · 13,251 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on March 8, 2005. F5 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 10,642 | $48.33 | $514,327.86 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,781 F2 · kind: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on March 8, 2005. Read SEC document |
| June 02, 2005 Filed Jun 3, 2005 17:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 13,251 | $32.61 | $432,129.69 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This exercise was made pursuant to a previously adopted plan complying with Rule 10b5-1(c). The plan was adopted on March 8, 2005. Read SEC document |
| June 01, 2005 Filed Jun 3, 2005 17:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 34,800 | $0.00 Strike: $48.32 | $0.00 |
DisclosureSEC source: 0001104659-05-026731 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,800 Underlying: common shares · 34,800 shares Expires 2015-05-31 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under rule 16b-3. The option becomes exercisable in annual increments of 11,600 on 06/01/06, 11,600 on 06/01/07, and 11,600 on 06/01/08. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.